Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Regulatory News
10/18/2024
CDE Solicits Comments on the Technical Guidelines for Clinical Risk Ma...
10/18/2024
NMPA Launches Pilot Reform for Staged Production of Biologicals
10/17/2024
NMPA Holds National Drug Distribution Supervision Work Conference
10/15/2024
CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...
10/15/2024
NMPA Issues the Application Procedures and Dossier Requirements for th...
10/15/2024
China Solicits Comments on Draft Compliance Guidelines for Pharmaceuti...
10/11/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Model-I...
10/11/2024
NMPA Announces Package Insert Revision of Sodium Gluconate Injection P...
10/10/2024
CDE Issues the Technical Guidelines for the Analysis and Handling of S...
10/10/2024
CDE Solicits Comments on the Proposed Announcement on Rewarding Intern...
10/9/2024
NMPA Announces Package Insert Revision of Mezlocillin Sodium Containin...
10/8/2024
CDE Issues the List of Reference Formulations for GQCE Studies (83rd B...
10/2/2024
Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...
10/2/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...
10/2/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...
10/2/2024
CDE Solicits Comments on the Proposed BE Study Guidelines for Five Gen...
10/2/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Writing...
10/2/2024
China Issues New Regulation on Network Data Security Management
10/1/2024
China and US to Renew Health Cooperation Following Washington Talks
9/26/2024
China Issues the Provisions for Investigator-Initiated Clinical Resear...
9/26/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...
9/26/2024
CDE Issues the Technical Guidelines for Vaccine Immunogenicity Bridgin...
9/26/2024
CDE Issues the Guidelines for BE Studies of Dydrogesterone Tablets and...
9/26/2024
China Accelerates Approval of Innovative Drugs, Boosts Global Collabor...
9/20/2024
NMPA Deputy Commissioner Meets with Danish Delegation
9/19/2024
CDE Issues the Technical Guidelines for Clinical Design of Denosumab I...
9/19/2024
CDE Issues the Technical Guidelines for Clinical Trials of Cardiac Arr...
9/13/2024
China Reports Increase in Innovative Drug Approvals
9/13/2024
CDE Issues the Pilot Work Plan for Patient-Centered Rare Disease Drug ...
9/12/2024
CDE Solicits Comments on Draft of the Implementation Suggestions and C...
Page:
4
/
8
Total number of articles:
224
:
[First]
[<<]
[2]
[3]
[4]
[5]
[6]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit